Trial Profile
Study on the treatment mode of stage IV diabetic retinopathy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 28 Nov 2017 New trial record